- Product
- 5 mil Tylenols will be released to market…100 per pharmacy
- by Jun 14, 2021 05:56am
- ‘Public Tylenol will be supplied,’ ‘Why is the government unnecessarily supplying Tylenol to every pharmacy?’ On the 11th, the pharmacists’ community heat up over the Tylenol supply issue. The issue was sparked with some distributors spreading the news that ‘public rationed Tylenol will be released in the market from the 14th.'
- Product
- Ask for Acetaminophen, instead of Tylenol
- by Kang, Shin-Kook Jun 8, 2021 09:12pm
- "If fever or muscle pain occurs after vaccination, ask for Acetaminophen to the pharmacy." As the Tylenol shortage continues, the movement to change public perception begins. Rep. Seo Young-seok of the Democratic Party of Korea visited the Korean Pharmaceutical Association Hall on the morning of the 4th and announced that he would start an SN
- Product
- Tylenol's sales at convenience stores rose 125% year-on-year
- by Jun 4, 2021 06:06am
- Convenience stores are also benefiting from the shortage of outpatient pharmacies' Tylenol as vaccination begins in earnest.Tylenol sales at convenience stores designated as household medicine rose. First of all, CU's Tylenol sales increased 125.5% year-on-year. According to sales from May 27 to May 31, when vaccinations for people aged 6
- Product
- Korean Tylenol is in stock
- by Jun 4, 2021 06:05am
- "It doesn't have to be original Tylenol." Pharmacists have launched a counterattack in connection with the Tylenol shortage. As Tylenol has been out of stock for months to respond to consumers due to recommendations from vaccination centers and health centers, pharmacists are trying to immediately inform them of fever and painkillers. They st
- Product
- Zuellig Pharma ends distribution at the end of this month
- by May 24, 2021 05:51am
- Zuellig Pharma Korea, a global drug distribution company, announced its order and return procedures to prevent confusion as of this month. According to pharmacies on the 24th, Zuellig Pharma Korea recently announced a re-announcement of the termination of the pharmacy distribution business to pharmacies and others. Although it has alrea
- Product
- Will Kypris become dominant in multiple myeloma markets?
- by Whang, byung-woo May 10, 2021 05:56am
- "New treatments will also emerge in the treatment of myeloma. However, its importance is still expected to continue when Kypris compares combined therapy features with a single formulation and other formulations." As multiple myeloma is difficult to completely heal and many recurrences occur, recurrence and non-responsive polymyeloma is consider
- Product
- Pharmacists & employees in their 20s receive Pfizer vaccine
- by May 7, 2021 06:01am
- Pharmacists and employees under the age of 30 who were excluded from the AZ vaccination are expected to receive the Pfizer vaccine next month. The KCDA announced on the 4th that the Pfizer vaccine for social essential personnel and military soldiers under the age of 30 who have been suspended from vaccinating AZ vaccine due to "thrombotic sid
- Product
- The price of Rotarix has also increased
- by Moon, sung-ho Apr 30, 2021 06:09am
- As prices have increased for cervical cancer vaccines and rotavirus vaccines that prevent neonatal enteritis, the burden on hospitals and clinics is increasing. Some medical organizations are raising the issue of unilateral price hikes for global pharmaceutical companies, but there is currently no clear solution. The medical staff who have
- Product
- Why are pharmacists in the AZ vaccination relay?
- by Apr 22, 2021 05:53am
- On social media, pharmacists' vaccination application reservation verification shots appeared in a row. "I made an appointment for vaccination", "I applied for it too" Since yesterday (19th), a vaccine application for pharmacies through the KCDA website has been in progress, and pharmacists who have completed reservations are sharing informa
- Product
- Korean bio-pharma companies attract attention at AACR 2021
- by Whang, byung-woo Apr 21, 2021 05:49am
- The AACR 2021 Annual Meeting, the largest meeting on cancer research in the world, took place from April 10th to April 15th. At the meeting, new combination therapies were introduced, raising expectations for the use of new mechanisms of action in the field of cancer treatment. Through a presentation of data on the use of nivolumab (Opdivo) i
